APA (7th ed.) Citation

Shennan, A. H., Simcox, R., Briley, A., & Poston, L. (2006). Authors response to: A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. BJOG: an international journal of obstetrics and gynaecology, 113(7), 851. https://doi.org/10.1111/j.1471-0528.2006.00955.x

Chicago Style (17th ed.) Citation

Shennan, A. H., R. Simcox, A. Briley, and L. Poston. "Authors Response to: A Randomised Controlled Trial of Metronidazole for the Prevention of Preterm Birth in Women Positive for Cervicovaginal Fetal Fibronectin: The PREMET Study." BJOG: An International Journal of Obstetrics and Gynaecology 113, no. 7 (2006): 851. https://doi.org/10.1111/j.1471-0528.2006.00955.x.

MLA (9th ed.) Citation

Shennan, A. H., et al. "Authors Response to: A Randomised Controlled Trial of Metronidazole for the Prevention of Preterm Birth in Women Positive for Cervicovaginal Fetal Fibronectin: The PREMET Study." BJOG: An International Journal of Obstetrics and Gynaecology, vol. 113, no. 7, 2006, p. 851, https://doi.org/10.1111/j.1471-0528.2006.00955.x.